We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

75 hedge funds and large institutions have $296M invested in TG Therapeutics in 2014 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

260% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 10

212% more call options, than puts

Call options by funds: $9.62M | Put options by funds: $3.09M

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

79% more capital invested

Capital invested by funds: $165M → $296M (+$131M)

14% more funds holding

Funds holding: 66 → 75 (+9)

Holders
75
Holders Change
+9
Holders Change %
+13.64%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
20
Increased
36
Reduced
10
Closed
10
Calls
$9.62M
Puts
$3.09M
Net Calls
+$6.54M
Net Calls Change
-$697K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$25.1M
2
RCM
RA Capital Management
Massachusetts
+$16.7M
3
HH
HWG Holdings
Texas
+$4.81M
4
VAM
Visium Asset Management
New York
+$4.68M
5
BIT
BlackRock Institutional Trust
California
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
-$23.6M
2
JP Morgan Chase
JP Morgan Chase
New York
-$10.8M
3
Jennison Associates
Jennison Associates
New York
-$4.37M
4
CCI
Columbus Circle Investors
-$2.97M
5
Millennium Management
Millennium Management
New York
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Sio Capital Management
New York
$1.63M +$1.34M +102,700 New
Ameriprise
27
Ameriprise
Minnesota
$1.58M +$71.5K +5,489 +6%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$1.47M +$893K +68,615 +282%
Invesco
29
Invesco
Georgia
$1.42M -$533K -40,951 -31%
MNBTD
30
Moody National Bank Trust Division
Texas
$1.33M +$1.1M +84,149 New
TCIM
31
TIAA CREF Investment Management
New York
$1.28M +$14.7K +1,131 +1%
BIM
32
BlackRock Investment Management
Delaware
$1.24M +$123K +9,424 +14%
Deutsche Bank
33
Deutsche Bank
Germany
$1.16M +$239K +18,320 +34%
Morgan Stanley
34
Morgan Stanley
New York
$1.11M +$656K +50,372 +254%
ARTA
35
A.R.T. Advisors
New York
$922K +$758K +58,245 New
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$809K +$101K +7,785 +18%
AQR Capital Management
37
AQR Capital Management
Connecticut
$767K +$254K +19,500 +67%
CS
38
Credit Suisse
Switzerland
$713K +$265K +20,340 +82%
WMSA
39
Weiss Multi-Strategy Advisers
New York
$570K +$13K +1,000 +3%
Charles Schwab
40
Charles Schwab
California
$545K – – –
DC
41
Deere & Company
Illinois
$524K +$431K +33,089 New
TA
42
Teachers Advisors
New York
$522K – – –
DCM
43
Driehaus Capital Management
Illinois
$455K +$374K +28,700 New
Creative Planning
44
Creative Planning
Kansas
$393K +$130K +10,000 +68%
Swiss National Bank
45
Swiss National Bank
Switzerland
$385K +$316K +24,300 New
NFA
46
Nationwide Fund Advisors
Ohio
$328K +$35.3K +2,708 +15%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$324K +$20.1K +1,545 +8%
VOYA Investment Management
48
VOYA Investment Management
Georgia
$310K – – –
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$308K – – –
AIG
50
American International Group
New York
$283K +$24.8K +1,904 +12%
1
2
3 4

TGTX Hedge Fund Activity: Q4 2014 in Review

75 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q4 2014, worth a combined $296M — up 79% from $165M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TGTX positions and 10 closed out — a net gain of 10 holders — while 36 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $25.1M. The largest seller was Bridger Management, cutting an estimated $23.6M.

  • 75 institutional investors held TG Therapeutics (TGTX) as of Q4 2014, up from 66 in Q3 2014.
  • Funds reported $296M of TG Therapeutics stock for Q4 2014, up 79% quarter-over-quarter.
  • 20 funds opened new TG Therapeutics positions in Q4 2014 and 10 closed out, a net change of +10 holders.
  • The largest TG Therapeutics buyer in Q4 2014 was Fidelity Investments, an estimated $25.1M added.
  • The largest TG Therapeutics seller in Q4 2014 was Bridger Management, an estimated $23.6M sold.

Based on aggregated 13F filings for Q4 2014.